Mini-Metagenomics Leads to Microbial Discovery

Researchers develop a method that combines the strengths of shotgun metagenomics and single-cell genome sequencing in a microfluidics-based platform.

Written byAbby Olena, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Bijah Spring, Yellowstone National ParkFLICKR, NPS / JACOB W. FRANKScientists searching for undiscovered microbial species have historically had a choice of two DNA-based techniques. The first is shotgun metagenomics, where researchers extract and sequence the DNA from an environmental sample that contains many community members. This technique can yield information about the species present in a community and their relative abundance, but works best for samples without too much diversity and doesn’t always reveal rare microbes.

The second option is single-cell sequencing, which has the advantage of providing full microbial genomes, but it can be labor-intensive and expensive.

Now, researchers have combined aspects of both strategies to develop a microfluidics-based mini-metagenomic method, which allows single-cell sequencing of many small groups of cells at once. The scientists described their work last week (July 7) in eLife.

The project arose from the desire to do large-scale, single-cell genome experiments, says Stephen Quake, a bioengineer at Stanford University. The resulting microfluidics-based method “brings the best of both worlds from what have been the two predominant techniques and allows us to explore complex ecosystems with a precision that’s never before been possible,” he adds.

Quake, postdoctoral fellow Brian Yu, and colleagues first added a mixture ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies